Logo image of BSX

BOSTON SCIENTIFIC CORP (BSX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BSX - US1011371077 - Common Stock

93.61 USD
+0.06 (+0.06%)
Last: 1/27/2026, 8:04:22 PM
93.61 USD
0 (0%)
After Hours: 1/27/2026, 8:04:22 PM
Fundamental Rating

5

Taking everything into account, BSX scores 5 out of 10 in our fundamental rating. BSX was compared to 184 industry peers in the Health Care Equipment & Supplies industry. BSX has an excellent profitability rating, but there are some minor concerns on its financial health. BSX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • BSX had positive earnings in the past year.
  • BSX had a positive operating cash flow in the past year.
  • BSX had positive earnings in 4 of the past 5 years.
  • BSX had a positive operating cash flow in each of the past 5 years.
BSX Yearly Net Income VS EBIT VS OCF VS FCFBSX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

  • BSX has a Return On Assets of 6.54%. This is amongst the best in the industry. BSX outperforms 86.96% of its industry peers.
  • BSX has a Return On Equity of 11.93%. This is amongst the best in the industry. BSX outperforms 88.04% of its industry peers.
  • The Return On Invested Capital of BSX (8.09%) is better than 84.24% of its industry peers.
  • BSX had an Average Return On Invested Capital over the past 3 years of 6.59%. This is below the industry average of 8.81%.
  • The last Return On Invested Capital (8.09%) for BSX is above the 3 year average (6.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.54%
ROE 11.93%
ROIC 8.09%
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.59%
ROIC(5y)5.7%
BSX Yearly ROA, ROE, ROICBSX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

  • BSX has a Profit Margin of 14.42%. This is amongst the best in the industry. BSX outperforms 91.30% of its industry peers.
  • BSX's Profit Margin has declined in the last couple of years.
  • BSX has a Operating Margin of 19.40%. This is amongst the best in the industry. BSX outperforms 92.39% of its industry peers.
  • In the last couple of years the Operating Margin of BSX has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 68.57%, BSX is in the better half of the industry, outperforming 75.54% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BSX has remained more or less at the same level.
Industry RankSector Rank
OM 19.4%
PM (TTM) 14.42%
GM 68.57%
OM growth 3Y0.91%
OM growth 5Y1.48%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.15%
GM growth 5Y-0.56%
BSX Yearly Profit, Operating, Gross MarginsBSX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

  • BSX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • BSX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BSX has been increased compared to 5 years ago.
  • BSX has a worse debt/assets ratio than last year.
BSX Yearly Shares OutstandingBSX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
BSX Yearly Total Debt VS Total AssetsBSX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • BSX has an Altman-Z score of 5.29. This indicates that BSX is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 5.29, BSX is in the better half of the industry, outperforming 78.80% of the companies in the same industry.
  • BSX has a debt to FCF ratio of 3.03. This is a good value and a sign of high solvency as BSX would need 3.03 years to pay back of all of its debts.
  • The Debt to FCF ratio of BSX (3.03) is better than 82.61% of its industry peers.
  • BSX has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
  • BSX has a Debt to Equity ratio (0.48) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 3.03
Altman-Z 5.29
ROIC/WACC0.83
WACC9.78%
BSX Yearly LT Debt VS Equity VS FCFBSX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B

2.3 Liquidity

  • BSX has a Current Ratio of 1.51. This is a normal value and indicates that BSX is financially healthy and should not expect problems in meeting its short term obligations.
  • BSX has a worse Current ratio (1.51) than 72.83% of its industry peers.
  • BSX has a Quick Ratio of 1.51. This is a bad value and indicates that BSX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BSX has a Quick ratio of 0.96. This is in the lower half of the industry: BSX underperforms 77.17% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 0.96
BSX Yearly Current Assets VS Current LiabilitesBSX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

8

3. Growth

3.1 Past

  • BSX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.00%, which is quite impressive.
  • The Earnings Per Share has been growing by 9.56% on average over the past years. This is quite good.
  • BSX shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.62%.
  • BSX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.30% yearly.
EPS 1Y (TTM)25%
EPS 3Y15.48%
EPS 5Y9.56%
EPS Q2Q%19.05%
Revenue 1Y (TTM)21.62%
Revenue growth 3Y12.1%
Revenue growth 5Y9.3%
Sales Q2Q%20.34%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.06% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 12.60% on average over the next years. This is quite good.
EPS Next Y22.12%
EPS Next 2Y18.13%
EPS Next 3Y16.37%
EPS Next 5Y15.06%
Revenue Next Year20.92%
Revenue Next 2Y16.08%
Revenue Next 3Y14.31%
Revenue Next 5Y12.6%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BSX Yearly Revenue VS EstimatesBSX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B
BSX Yearly EPS VS EstimatesBSX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 31.73, BSX can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, BSX is valued a bit cheaper than the industry average as 73.91% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 28.87, BSX is valued at the same level.
  • With a Price/Forward Earnings ratio of 26.73, BSX can be considered very expensive at the moment.
  • BSX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BSX is cheaper than 75.00% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 25.96. BSX is around the same levels.
Industry RankSector Rank
PE 31.73
Fwd PE 26.73
BSX Price Earnings VS Forward Price EarningsBSX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BSX indicates a somewhat cheap valuation: BSX is cheaper than 71.74% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BSX indicates a somewhat cheap valuation: BSX is cheaper than 77.72% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 36.3
EV/EBITDA 29.19
BSX Per share dataBSX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of BSX may justify a higher PE ratio.
  • BSX's earnings are expected to grow with 16.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.43
PEG (5Y)3.32
EPS Next 2Y18.13%
EPS Next 3Y16.37%

0

5. Dividend

5.1 Amount

  • No dividends for BSX!.
Industry RankSector Rank
Dividend Yield 0%

BOSTON SCIENTIFIC CORP / BSX FAQ

What is the ChartMill fundamental rating of BOSTON SCIENTIFIC CORP (BSX) stock?

ChartMill assigns a fundamental rating of 5 / 10 to BSX.


What is the valuation status for BSX stock?

ChartMill assigns a valuation rating of 4 / 10 to BOSTON SCIENTIFIC CORP (BSX). This can be considered as Fairly Valued.


How profitable is BOSTON SCIENTIFIC CORP (BSX) stock?

BOSTON SCIENTIFIC CORP (BSX) has a profitability rating of 7 / 10.


What is the valuation of BOSTON SCIENTIFIC CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BOSTON SCIENTIFIC CORP (BSX) is 31.73 and the Price/Book (PB) ratio is 5.93.


Can you provide the expected EPS growth for BSX stock?

The Earnings per Share (EPS) of BOSTON SCIENTIFIC CORP (BSX) is expected to grow by 22.12% in the next year.